SATIVEX - Trademark Details
Status: 641 - Non-Final Action - Mailed
Serial Number
79266020
Word Mark
SATIVEX
Status
641 - Non-Final Action - Mailed
Status Date
2022-01-03
Filing Date
2019-07-17
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
O30
Employee Name
LOOK, JEFFREY J
Statements
Goods and Services
Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pharmaceutical preparations for the treatment of neurological conditions and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes; pharmaceutical preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-09-04
Primary Code
005
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
98 - Unknown
Address
Please log in with your Justia account to see this address.
Correspondences
Name
MICHAEL T OLSEN
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
0805396
International Registration Date
2003-01-03
International Publication Date
2019-08-22
International Renewal Date
2023-01-03
Auto Protection Date
2021-02-22
International Status
001 - Request for extension of protection established
International Status Date
2019-08-22
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event Date | Event Description |
2019-08-22 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
2019-08-26 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
2019-09-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-09-10 | APPLICATION FILING RECEIPT MAILED |
2019-09-21 | ASSIGNED TO EXAMINER |
2020-07-28 | ASSIGNED TO EXAMINER |
2020-07-30 | NON-FINAL ACTION WRITTEN |
2020-07-31 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-08-12 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
2020-08-14 | NON-FINAL ACTION WRITTEN |
2020-08-15 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-09-09 | REFUSAL PROCESSED BY MPU |
2020-09-10 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2020-09-26 | REFUSAL PROCESSED BY IB |
2021-01-27 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
2021-01-27 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2021-02-13 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
2021-03-08 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-03-08 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-03-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-05-03 | FINAL REFUSAL WRITTEN |
2021-05-03 | FINAL REFUSAL E-MAILED |
2021-05-03 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2021-09-15 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-09-15 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-09-15 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
2021-09-15 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-11-03 | EXPARTE APPEAL RECEIVED AT TTAB |
2021-11-03 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
2021-11-03 | EX PARTE APPEAL-INSTITUTED |
2021-11-03 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2021-11-08 | ASSIGNED TO LIE |
2021-11-09 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2021-11-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-11-09 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-11-20 | NEW REPRESENTATIVE AT IB RECEIVED |
2022-01-03 | NON-FINAL ACTION WRITTEN |
2022-01-03 | NON-FINAL ACTION E-MAILED |
2022-01-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |